What is Geneveve™?
Viveve, a women’s sexual health company based in California, has introduced a treatment specifically meant to treat vaginal laxity in women: Geneveve™. Vaginal laxity is a common issue for women due to childbirth or aging. There are many symptoms associated with vaginal laxity in women, including:
Stress urinary incontinence (dribbling after you cough, sneeze, laugh, or exercise)
Urge incontinence (strong or sudden need to urinate)
Looseness of the vaginal wall or lack of tightness
Vaginal dryness & lack of lubrication during sexual activity
Lack of sensation & sexual desire
Unlike other vaginal rejuvenation treatments such as ThermiVa® and diVa®, Geneveve™ is the only treatment that uses algorithmically-controlled cooling to help distribute energy evenly across tissue for optimal treatment.
Who is a Good Candidate for Geneveve™?
Women who are experiencing vaginal laxity due to aging or childbirth can often benefit from this procedure. It is advised that individuals who are pregnant wait until after birth to undergo this treatment. Women who are menstruating should also wait to undergo Geneveve™ treatments, as increased blood flow in the area and impede the penetration of RF energy. Furthermore, patients with an automatic implantable cardiovascular/defibrillator (AICD) should not receive this treatment. A consultation can help to best determine if this procedure is right for you.
The Geneveve™ Non-Surgical Vaginal Rejuvenation Procedure
The Geneveve™ procedure entails the use of a treatment wand attached to a table-top unit. Using tiny pulses of cryogen-cooled monopolar radiofrequency (CMRF) energy, Geneveve™ works to selectively heat vaginal tissues, causing contraction. This tightens the tissues and stimulates new collagen formation. One treatment only takes about 30 minutes, and no anesthesia is required.
Because the overlying tissues are not damaged during a Geneveve™ treatment, there is little to no downtime involved. Side effects that may occur include mild redness, swelling, or a tingling sensation after treatment, which should resolve quickly. Collagen formation will take place over the course of two to three months with continued improvement for six to 12 months.
How does Geneveve™ work?
Watch the video below to learn more.
Click here to download the Geneveve™ Patient Info brochure.
Click here to download the Geneveve™ FAQs document.
Living with urinary
incontinence isn't living!
Urinary incontinence is an involuntary leakage of urine. It is a common and distressing medical problem that is often treatable through proper diagnosis and therapies. Our urologists focus first on the medical conditions causing the incontinence. Then through a variety of tests we determine the cause and proper therapy to improve the problem.
Some of the therapies we use to treat incontinence include:
Pessary care – This alternative therapy for women uses the insertion of a removable medical device into the patient’s vagina to support and tighten weak muscles in the pelvic area to improve or restore urinary continence.
E-Stim – This therapy uses electrical stimulation to retrain and strengthen weak urinary muscles and improve bladder control.
Biofeedback – With this modern therapy, patients are taught to exercise and strengthen pelvic and abdominal muscles. A simple instrument records small electronic signals that are produced when the patient successfully contracts the correct muscles, helping him or her gain greater control over urinary muscle activity.